ExitValue.ai

Updated November 9, 2026 · Based on disclosed M&A transactions, 2018–2026

Is my offer fair?

If a private equity platform, a DSO or a larger competitor has made you an offer, the first question is what multiple of EBITDA it implies and how that compares with what businesses your size have actually sold for. The second is how much of the price you get at closing.

Enter the offer below. We compare it with the median and middle half of disclosed deals of the same size in your industry. We only show a comparison where enough deals have been disclosed to publish one.

Check your offer

Published small-deal medians

These are the industries where enough disclosed deals under $100M of enterprise value reported an EBITDA multiple to publish a median. Size matters: across our data, smaller deals sell at lower multiples than platform-sized ones, and they moved less when interest rates rose.

IndustryDeal size (EV)Median EV/EBITDAMiddle halfDeals
Ambulatory Surgery Center$5M–$25M8.1x5.47x–11.38x20
Ambulatory Surgery Center$25M–$100M9.1x6.72x–12.3x10
Dental Practice$5M–$25M6.95x6.5x–8.32x10
Durable Medical EquipmentUnder $5M5.3x4.3x–7x11
Durable Medical Equipment$5M–$25M5x4.65x–5.72x12
Electronics$25M–$100M9.12x6.73x–18.38x10
Home HealthUnder $5M4.7x3.9x–6.25x25
Industrial Equipment$25M–$100M8.41x6.17x–11.29x18
Medical Devices$25M–$100M13x10.3x–23.25x13
Oil & Gas Services$25M–$100M4.01x2.25x–9.11x13
Primary Care PracticeUnder $5M3.6x3.4x–4.6x11
SaaS$5M–$25M10.72x8.24x–17.78x14
SaaS$25M–$100M12.8x5.74x–19.63x10
Specialty Medical Practice$5M–$25M5.9x5.1x–8.2x15
Wholesale Distribution$25M–$100M6.17x4.77x–8.79x16

Source: disclosed transactions from a licensed M&A database, SEC EDGAR filings and verified press releases, 2018–2026. Full breakdowns are on the benchmarks pages.

The price is only half the offer

Two offers with the same headline number can be worth very different amounts. Check these before comparing them:

Common questions

How do I know if an offer for my business is fair?

Divide the offer price by your trailing twelve-month EBITDA to get the multiple it implies, then compare that with disclosed deals of a similar size in your industry. Then look past the headline: how much is paid in cash at closing, what is deferred into rollover equity, an earnout or a seller note, and which EBITDA figure the buyer used.

Is the offer price what I actually receive?

Usually not. Most offers are on a cash-free, debt-free basis, so the business’s debt is paid off from the price and any cash stays with you. A working-capital target set in the purchase agreement can raise or lower the price at closing. Transaction fees and taxes come off what you keep.

What is rollover equity?

Part of the price paid as shares in the buyer’s company instead of cash. Private equity platforms and DSOs commonly ask owners to roll part of their proceeds. It can be worth more or less than its stated value when the platform is later sold, and you usually cannot sell it before then.

Should I sign a letter of intent with exclusivity?

An LOI with an exclusivity period stops you talking to other buyers while the first one does diligence. That is normal, but it is the point where your leverage drops, so it is worth testing the market before you sign rather than after.

Get a number for your business

The median is the starting point. The full valuation adjusts for your margins, growth, customer or payer concentration and how much the business depends on you.

Value My Business →

This page is general information, not advice on a specific offer.